Lapatinib inhibits doxorubicin induced migration of HER2-positive breast cancer cells
Crossref DOI link: https://doi.org/10.1007/s10787-020-00711-9
Published Online: 2020-05-06
Published Print: 2020-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Chintalaramulu, Naveen
Vadivelu, Raja
Nguyen, Nam-Trung
Cock, Ian Edwin
Text and Data Mining valid from 2020-05-06
Version of Record valid from 2020-05-06
Article History
Received: 28 January 2020
Accepted: 15 April 2020
First Online: 6 May 2020
Compliance with ethical standards
:
: All authors declare no conflicts of interest.